BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24306027)

  • 21. MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes.
    Mraz M; Pospisilova S; Malinova K; Slapak I; Mayer J
    Leuk Lymphoma; 2009 Mar; 50(3):506-9. PubMed ID: 19347736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-92a-3p overexpression in peripheral blood mononuclear cells is an independent predictor of prolonged overall survival of patients with chronic lymphocytic leukemia.
    Papageorgiou SG; Diamantopoulos MA; Kontos CK; Bouchla A; Vasilatou D; Bazani E; Scorilas A; Pappa V
    Leuk Lymphoma; 2019 Mar; 60(3):658-667. PubMed ID: 29911923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA expression in chronic lymphocytic leukemia developing autoimmune hemolytic anemia.
    Ferrer G; Navarro A; Hodgson K; Aymerich M; Pereira A; Baumann T; Monzo M; Moreno C; Montserrat E
    Leuk Lymphoma; 2013 Sep; 54(9):2016-22. PubMed ID: 23286334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-codingRNA sequence variations in human chronic lymphocytic leukemia and colorectal cancer.
    Wojcik SE; Rossi S; Shimizu M; Nicoloso MS; Cimmino A; Alder H; Herlea V; Rassenti LZ; Rai KR; Kipps TJ; Keating MJ; Croce CM; Calin GA
    Carcinogenesis; 2010 Feb; 31(2):208-15. PubMed ID: 19926640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiRNA expression profile of chronic lymphocytic leukemia patients with 13q deletion.
    Hernández-Sánchez M; Rodríguez-Vicente AE; Hernández JÁ; Lumbreras E; Sarasquete ME; Martín AÁ; Benito R; Vicente-Gutiérrez C; Robledo C; Heras Nde L; Rodríguez JN; Alcoceba M; Coca AG; Aguilar C; González M; Hernández-Rivas JM
    Leuk Res; 2016 Jul; 46():30-6. PubMed ID: 27111859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased chronic lymphocytic leukemia proliferation upon IgM stimulation is sustained by the upregulation of miR-132 and miR-212.
    Tavolaro S; Colombo T; Chiaretti S; Peragine N; Fulci V; Ricciardi MR; Messina M; Bonina S; Brugnoletti F; Marinelli M; Di Maio V; Mauro FR; Del Giudice I; Macino G; Foà R; Guarini A
    Genes Chromosomes Cancer; 2015 Apr; 54(4):222-34. PubMed ID: 25645730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of miR-15/16 in CLL.
    Pekarsky Y; Croce CM
    Cell Death Differ; 2015 Jan; 22(1):6-11. PubMed ID: 24971479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.
    Zhu DX; Zhu W; Fang C; Fan L; Zou ZJ; Wang YH; Liu P; Hong M; Miao KR; Liu P; Xu W; Li JY
    Carcinogenesis; 2012 Jul; 33(7):1294-301. PubMed ID: 22610076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model.
    Chiang CL; Goswami S; Frissora FW; Xie Z; Yan PS; Bundschuh R; Walker LA; Huang X; Mani R; Mo XM; Baskar S; Rader C; Phelps MA; Marcucci G; Byrd JC; Lee LJ; Muthusamy N
    Blood; 2019 Aug; 134(5):432-444. PubMed ID: 31151986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance.
    Calin GA; Croce CM
    Semin Oncol; 2006 Apr; 33(2):167-73. PubMed ID: 16616063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-4 Up-Regulates MiR-21 and the MiRNAs Hosted in the CLCN5 Gene in Chronic Lymphocytic Leukemia.
    Ruiz-Lafuente N; Alcaraz-García MJ; Sebastián-Ruiz S; García-Serna AM; Gómez-Espuch J; Moraleda JM; Minguela A; García-Alonso AM; Parrado A
    PLoS One; 2015; 10(4):e0124936. PubMed ID: 25909590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1.
    Mraz M; Chen L; Rassenti LZ; Ghia EM; Li H; Jepsen K; Smith EN; Messer K; Frazer KA; Kipps TJ
    Blood; 2014 Jul; 124(1):84-95. PubMed ID: 24787006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential microRNA profiles and their functional implications in different immunogenetic subsets of chronic lymphocytic leukemia.
    Papakonstantinou N; Ntoufa S; Chartomatsidou E; Papadopoulos G; Hatzigeorgiou A; Anagnostopoulos A; Chlichlia K; Ghia P; Muzio M; Belessi C; Stamatopoulos K
    Mol Med; 2013 May; 19(1):115-23. PubMed ID: 23615967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials.
    Wojdacz TK; Amarasinghe HE; Kadalayil L; Beattie A; Forster J; Blakemore SJ; Parker H; Bryant D; Larrayoz M; Clifford R; Robbe P; Davis ZA; Else M; Howard DR; Stamatopoulos B; Steele AJ; Rosenquist R; Collins A; Pettitt AR; Hillmen P; Plass C; Schuh A; Catovsky D; Oscier DG; Rose-Zerilli MJJ; Oakes CC; Strefford JC
    Blood Adv; 2019 Aug; 3(16):2474-2481. PubMed ID: 31434681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells.
    Rozovski U; Calin GA; Setoyama T; D'Abundo L; Harris DM; Li P; Liu Z; Grgurevic S; Ferrajoli A; Faderl S; Burger JA; O'Brien S; Wierda WG; Keating MJ; Estrov Z
    Mol Cancer; 2013 Jun; 12():50. PubMed ID: 23725032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181.
    Pekarsky Y; Santanam U; Cimmino A; Palamarchuk A; Efanov A; Maximov V; Volinia S; Alder H; Liu CG; Rassenti L; Calin GA; Hagan JP; Kipps T; Croce CM
    Cancer Res; 2006 Dec; 66(24):11590-3. PubMed ID: 17178851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival.
    Rossi S; Shimizu M; Barbarotto E; Nicoloso MS; Dimitri F; Sampath D; Fabbri M; Lerner S; Barron LL; Rassenti LZ; Jiang L; Xiao L; Hu J; Secchiero P; Zauli G; Volinia S; Negrini M; Wierda W; Kipps TJ; Plunkett W; Coombes KR; Abruzzo LV; Keating MJ; Calin GA
    Blood; 2010 Aug; 116(6):945-52. PubMed ID: 20393129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Number of Overlapping AID Hotspots in Germline IGHV Genes Is Inversely Correlated with Mutation Frequency in Chronic Lymphocytic Leukemia.
    Yuan C; Chu CC; Yan XJ; Bagnara D; Chiorazzi N; MacCarthy T
    PLoS One; 2017; 12(1):e0167602. PubMed ID: 28125682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway.
    Wang LQ; Kwong YL; Kho CS; Wong KF; Wong KY; Ferracin M; Calin GA; Chim CS
    Mol Cancer; 2013 Dec; 12():173. PubMed ID: 24373626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia.
    Baer C; Claus R; Frenzel LP; Zucknick M; Park YJ; Gu L; Weichenhan D; Fischer M; Pallasch CP; Herpel E; Rehli M; Byrd JC; Wendtner CM; Plass C
    Cancer Res; 2012 Aug; 72(15):3775-85. PubMed ID: 22710432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.